Late Phase Drug Development World Americas 2010

Quick links

networking & contacts

conference details

Conference:

Pre-conference workshop

23 March 9am - 5pm

Day 1

24 March 8:30am - 6pm

Day 2

25 March 8:30am - 5:30pm

Post-conference workshop

26 March 9am - 5pm

Venue:
Hyatt Regency Princeton, NJ, United States

our speakers

Dr Chris Allen

Head of Global Information Management

Merck

Dr Danica Marinac-Dabic

Director, Division of Epidemiology

FDA

Dr Jens Rienhold

Head, Global Non Interventional Studies

Bayer Schering AG

Beat Wilder

Global Head of Clinical Quality Assurance

Hoffman La Roche

Dr Gilbert L’Italien

Executive Director, Global Health Outcomes

Bristol Myers Squibb

The 'must attend' late phase drug development conference in America

Late phase drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency.

As a result, Health Network Communications is delighted to announce the first ever strategic forum in the US addressing the major challenges in conducting strategic and compliant late stage studies.

Introducing Medidata Solutions

As an exhibitor of this event, Medidata is pleased to offer you a discounted registration of 50% until the 12th Feb. We hope you will be able to attend and look forward to meeting you at the event. To register either book online or call +44 (0) 207 608 7055 and quote your discount voucher code as: LMPWME

>> Register for the 50% discount rate
>> Full conference programme
>> Full speaker details

Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments.

Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer™), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®).

Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
www.mdsol.com

Want to find out more about Late Phase Drug Development World Americas 2010?

» Request brochure

Register as a VIP guest of Medidata

As a VIP guest of Medidata you can register for 50% off the standard ticket price.

Don't forget to quote your discount voucher code as: LMPWME

» Register now was a VIP guest

Medidata is pleased to offer you a discounted registration of 50% until the 12th Feb.

To register either book online or call +44 (0) 207 608 7055 to speak to a customer service representative.

Don't forget to quote your discount voucher code as: LMPWME